Estradiol-containing oral contraceptive

Long-acting reversible contraceptives (LARC)
Background
Type Hormonal
First use 1993 (Finland)
Pregnancy rates (first year)
Perfect use ?
Typical use ?
Usage
Reversibility Yes
User reminders ?
Advantages and disadvantages
STD protection No

Combined oral contraceptives that contain natural estradiol or an estradiol ester (e.g., estradiol valerate) include:[1][2][3]

It is hypothesized that these contraceptives may pose less of a risk of blood clots than contraceptives containing ethinyl estradiol, which is the conventional estrogen that is used in oral contraceptives, but this has yet to be proven.[6] However, incidence of irregular vaginal bleeding may be higher with estradiol-containing contraceptives in relation to the fact that estradiol is a weaker estrogen than ethinyl estradiol in the endometrium.[3]

Estradiol, mainly as esters including estradiol valerate, estradiol cypionate, and estradiol enanthate, is the exclusive estrogen used in combined injectable contraceptives.[7]

See also

References

  1. De Leo V, Musacchio MC, Cappelli V, Piomboni P, Morgante G (2016). "Hormonal contraceptives: pharmacology tailored to women's health". Human Reproduction Update. 22 (5): 634–46. doi:10.1093/humupd/dmw016. PMID 27307386.
  2. Stanczyk FZ, Archer DF, Bhavnani BR (2013). "Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment". Contraception. 87 (6): 706–27. doi:10.1016/j.contraception.2012.12.011. PMID 23375353.
  3. 1 2 3 Fruzzetti F, Bitzer J (2010). "Review of clinical experience with estradiol in combined oral contraceptives". Contraception. 81 (1): 8–15. doi:10.1016/j.contraception.2009.08.010. PMID 20004267.
  4. Guida M, Bifulco G, Di Spiezio Sardo A, Scala M, Fernandez LM, Nappi C (2010). "Review of the safety, efficacy and patient acceptability of the combined dienogest/estradiol valerate contraceptive pill". International Journal of Women's Health. 2: 279–90. doi:10.2147/IJWH.S6954. PMC 2990895Freely accessible. PMID 21151673.
  5. Burke A (2013). "Nomegestrol acetate-17b-estradiol for oral contraception". Patient Preference and Adherence. 7: 607–19. doi:10.2147/PPA.S39371. PMC 3702550Freely accessible. PMID 23836965.
  6. Nelson AL (2015). "An update on new orally administered contraceptives for women". Expert Opinion on Pharmacotherapy. 16 (18): 2759–72. doi:10.1517/14656566.2015.1100173. PMID 26512437.
  7. http://www.wjpps.com/download/article/1412071798.pdf


This article is issued from Wikipedia - version of the 10/23/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.